Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions

Article

Abstract: Objectives: CYP2D6 drug-metabolising enzyme has been shown to be involved in fluoxetine metabolism i

Palabras claves:

CYP2C9, CYP2D6, Selective serotonin reuptake inhibitors

Autores:

Adrián LLerena, Berecz R., Dorado P., González A.P., Penãs-Lledó E.M.

Fuentes:

scopus